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The regulatory mechanisms controlling expression of the major histocompatibility complex (MHC) class II
genes involve several cis-acting DNA elements, including the X and Y boxes. These two elements are conserved
within all murine and human class II genes and are required for accurate and efficient transcription from MHC
class II promoters. Interestingly, the distance between the X and Y elements is also evolutionarily conserved at
18 to 20 bp. To investigate the function of the invariant spacing in the human MHC class II gene, HLA-DRA,
we constructed a series of spacing mutants which alters the distance between the X and Y elements by integral
and half-integral turns of the DNA helix. Transient transfection of the spacing constructs into Raji cells
revealed that inserting integral turns of the DNA helix (+20 and + 10 bp) did not reduce promoter activity,
while inserting or deleting half-integral turns of the DNA helix (+15, +5, and -5 bp) drastically reduced
promoter activity. The loss of promoter function in these half-integral turn constructs was due neither to the
inability of the X and Y elements to bind proteins nor to improper binding of the X- and Y-box-binding
proteins. These data indicate that the X and Y elements must be aligned on the same side of the DNA helix to
ensure normal function. This requirement for stereospecific alignment strongly suggests that the X- and Y-box-
binding proteins either interact directly or are components of a larger transcription complex which assembles
on one face of the DNA double helix.
The interaction between nuclear proteins and DNA is
fundamental to transcriptional regulation in eukaryotic cells
(reviewed in references 37, 41, and 47). DNA-binding pro-
teins further interact with one another, both at neighboring
DNA sites and over long distances, to form complex net-
works of protein-DNA and protein-protein interactions (24,
46, 48, 60). Our knowledge of protein-DNA interactions is
rapidly increasing as cis-acting DNA elements and their
cognate sequence-specific binding proteins are identified in
many eukaryotic systems (28, 37, 41). Despite these ad-
vances in our understanding of protein-DNA interactions,
much remains to be learned about protein-protein interac-
tions and the complex network of interactions which control
gene expression.
The class II major histocompatibility complex (MHC)
antigens are involved in the initiation and control of the
immune response (reviewed in references 29 and 54). These
molecules function in the presentation of self and foreign
antigens to class II-restricted, antigen-specific T cells (4, 52).
Class II MHC molecules are expressed on a limited number
of cells, including B cells, thymic epithelial cells, dendritic
cells, glial cells, activated macrophages, and T cells (25, 51,
57, 59). In addition, class II MHC expression can be induced
by gamma interferon in a number of class II-negative cells
such as endothelial cells and fibroblasts (2, 12, 45). Expres-
sion of these genes is coordinated for the human DP, DQ,
and DR a- and ,B-chain genes and the class TI-associated
invariant (Ii)-chain gene (31, 35, 44). The coordinate, induc-
ible, and cell-type-specific expression of class II molecules is
tightly regulated (32). Complex regulation is necessary, as
aberrant expression of these molecules has been implicated
in immune dysfunction (7, 38, 49). Because of their biologi-
cal importance, there is great interest in understanding the
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mechanisms responsible for the regulation of MHC class II
gene expression.
Within the 5' promoter region of the MHC class II genes,
several cis-acting regulatory sequences have been shown to
function in inducible and basal gene expression (11, 14, 53,
55, 56, 61). The X element, Y element, and intervening
spacer region, collectively called the class TI box, are
conserved in all murine and human class TI genes and are
required for accurate and efficient transcription from the
MHC class TI promoters, as demonstrated by transient
transfection analysis, in vitro transcription studies, and
transgenic mice studies (18, 53, 64). Through gel mobility
shift assays and screening of expression libraries, multiple
X- and Y-box-binding proteins have been identified (6, 9, 15,
17, 34, 42, 50, 55).
In all human and murine class II genes, the spacing
between the X and Y elements is highly conserved at 18 to 20
bp but is variable in sequence (30). We hypothesized that
this conserved, two-helical-turn spacing may be required to
align the X and Y elements on the same side of the DNA
helix, thereby allowing the X- and Y-box-binding proteins to
directly interact or to participate in the assembly of a larger
promoter complex. A similar stereospecific alignment re-
quirement between cis-acting promoter elements has been
identified in both prokaryotic and eukaryotic systems.
In the simian virus 40 early promoter and the adenovirus
type 2 Elb promoter, proper function requires correct ste-
reospecific alignment of the GC boxes with the TATA
element or the upstream enhancer sequence (58, 63). In
RNA polymerase I-dependent transcription, transcription of
the Xenopus ribosomal DNA gene is strongly affected by the
stereospecific alignment between the upstream and core
domains (43). The role of spacing has also been implicated in
determining whether the U6 and 7SK RNA genes of Arabi-
dopsis thaliana are transcribed by RNA polymerase I or
RNA polymerase 11 (62). In the prokaryotic systems, spac-
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ing has been shown to be important in the repression of the
ara, gal, and deo operons in Escherichia coli and in the
proper function of X repressor (13, 20, 26, 27, 36). Collec-
tively, these studies imply that precise assembly of the
preinitiation complex in both prokaryotes and eukaryotes
requires protein-protein interactions.
In this report, we investigate the function of the conserved
spacing between the X and Y boxes of the DRA promoter.
To address this question, we altered the distance between
the X and Y boxes by approximately integral (10-bp) or
half-integral (5-bp) turns of the DNA helix. These alternately
spaced DRA promoters were functionally assessed by tran-
sient transfection and Si nuclease analyses. These results
indicate that promoter function can be drastically diminished
when half-integral turns of the DNA helix are either inserted
or deleted from the spacer region between the X and Y
boxes. In contrast, promoter function is maintained, and
actually enhanced, when integral turns of the helix are
inserted into the X,Y spacer region. Further studies reveal
that loss of promoter function upon alterations of the stereo-
specific alignment between the X and Y elements is not due
to the inability of these elements to bind proteins, nor does
it affect which DNA residues are contacted by the sequence-
specific DNA-binding proteins. These data strongly suggest
that the loss of promoter function accompanied by altered
stereospecific alignment of the X and Y boxes may be due to
the inability of the X- and Y-box-binding proteins to directly
interact or to the inability of these proteins to participate in
the assembly of a functional promoter-proximal transcrip-
tion complex.
MATERIALS AND METHODS
Cell culture and transfection. Raji is a human Epstein-Barr
virus-positive Burkitt's lymphoma cell line. Cells were
grown in RPMI 1640 supplemented with 8% fetal calf serum
and 2 mM glutamine. Transient transfections were per-
formed by electroporation as previously described (56).
Plasmids. Deletion mutants 5'A-56 and 5'A-56X+Y have
been previously described (55). Briefly, 5'A-56 contains 56
bp of 5'-flanking sequences of the HLA-DRA gene fused to
the bacterial chloramphenicol acetyltransferase (CAT) gene.
5'A-56X+Y was obtained by linearizing 5'A-56 with XbaI,
followed by treatment with Klenow enzyme to form blunt
ends and insertion of a 50-bp oligonucleotide containing the
wild-type DRA X element, 19-bp spacer, and the Y element.
The spacer constructs were made identically to 5'A-56X+Y
except that oligonucleotides containing spacers varying in
length were used as inserts. Dideoxynucleotide sequencing
was performed directly from the double-stranded plasmid to
confirm the orientation of the oligonucleotide insert.
CAT assays. CAT activity was determined as previously
described (56). Following visualization by autoradiography,
CAT activity was quantitated by scintillation counting sec-
tions of the thin-layer chromatography plate containing the
acetylated and unacetylated reaction products. Percent acet-
ylation was calculated from the counts per minute in the
acetylated spots compared with those in the total. Relative
CAT activity was calculated by normalizing the percent
acetylation of each construct to that of the wild-type 5'A-
56X+Y control, which was arbitrarily assigned a value of
1.00.
S1 nuclease protection analysis. Total cellular RNA was
prepared from Raji cells 24 h following transfection and
analyzed by Si nuclease protection assay as described
previously (5, 10, 40). The radiolabeled, antisense RNA
probe used in this assay was derived from the pGEM-DRA-
CAT plasmid (3). The probe encompasses 293 bp of the DRA
upstream region, including the start site for transcription,
and 266 bp of the CAT structural gene.
Nuclear extracts and competitor oligonucleotides. Nuclear
extracts were prepared from Raji and Namalwa cells as
previously described (16). Competitor oligonucleotides con-
taining the spacing alterations were made by using the
polymerase chain reaction as follows: 6.5 x 10-5 pmol of
synthetic, single-stranded oligonucleotides encompassing
the coding strand and 150 pmol of primers complementary to
the 5' and 3' ends of the coding and noncoding strands,
respectively, were allowed to denature, anneal, and fill in
through 30 cycles in a Cetus thermocycler. Reaction mix-
tures contained 50 mM KCl, 10 mM Tris-HCl (pH 8.0), 1.5
mM MgCl2, 0.01% gelatin, 0.01% Triton X-100, 0.25 mM
deoxynucleoside triphosphate, and 2 U of Taq enzyme.
Polymerase chain reaction products were extracted with
phenol-chloroform, ethanol precipitated, heated to 95°C, and
then cooled slowly to room temperature to anneal the
complementary strands. These double-stranded products
were quantitated both by spectrophotometric reading at 260
nm and by relative intensity of ethidium staining on an
agarose gel. The quality of the double-stranded products was
assessed by electrophoresis through a 12% denaturing poly-
acrylamide gel and subsequent ethidium staining.
Double-stranded competitors, X + spacer and Y + spacer,
are 36- and 33-bp oligonucleotides spanning either the X box
and spacer sequences or the Y box and spacer sequences.
These oligonucleotides have been previously described in
detail (55).
Electrophoretic mobility shift assays. The procedure has
been described in detail (22, 23). Radiolabeled probes were
prepared as previously described (56). Binding reaction
mixtures were prepared in 20-,u volumes and contained 50
mM NaCl, 1 mM dithiothreitol, 0.5 mM EDTA, 1 mM
Tris-HCl (pH 7.6), 2.5 mM MgCl2, 2 ,ug of poly(dI-
dC) poly(dI-dC) (Pharmacia), 4 ,ug of nuclear extract pro-
tein, and 80,000 counts of end-labeled oligonucleotide probe.
Samples were incubated for 30 min at room temperature and
then electrophoresed through a 6% polyacrylamide gel con-
taining 25 mM Tris-HCI, 190 mM glycine, and 1 mM EDTA.
Competitor DNA was incubated with the nuclear extract 5
min before addition of labeled probe.
Methylation interference analysis. The procedure was per-
formed as described previously (1), with the following mod-
ifications. Probes used in the binding reaction were prepared
by end labeling one strand of a synthetic oligonucleotide
with T4 polynucleotide kinase. Subsequently, the kinase
enzyme was inactivated by boiling, equal molar amounts of
the complementary strand were annealed, and the labeled
double-stranded oligonucleotides were separated from unin-
corporated radionucleotides by passage over a NENSORB
20 nucleic acid purification column (New England Nuclear).
Electrophoretic mobility shift reactions were scaled up
eightfold and performed as described above. After a 2-h
exposure at -70°C, the DNA-protein complexes and free
probe were excised from the gel. The DNA was electro-
phoresed from the acrylamide strips by using a vertical
electrophoresis apparatus and collected in SpectraPor 1000
dialysis membrane containing 250 ,ul of 89 mM Tris-borate-2
mM EDTA (pH 8.0) buffer. Following phenol-chloroform
extractions and ethanol precipitation, the DNA was resus-
pended in 20 ,ul of distilled H20. Piperidine cleavage was
performed at 95°C for 20 min by adding 25 ,ul of 2 M
piperidine to each DNA sample. Following cleavage, sam-
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FIG. 1. Plasmid constructs of the HLA-DRA promoter containing altered spacing between the X and Y elements. Oligonucleotides used
for insertion and deletion constructs are shown. Nucleotides are numbered relative to the transcriptional start site. All insertions are made
at position -85 bp of an otherwise unaltered DRA promoter. Deletion constructs were made by removing bracketed nucleotides. Construct
name represents circular plasmid after mutated oligonucleotides were cloned into the 5'A&-56 plasmid. Spacing between X and Y reflects the
total number (the wild-type 19 bp and any insertions or deletions) of nucleotides separating the two elements. Approximate number of helical
tums was calculated on the basis of 10 nucleotides per tum of the DNA double helix. 5'A-56X+Y represents the wild-type control.
pies were precipitated by adding 1 ml of sec-butanol, spun at
10,000 rpm for 5 min, resuspended in 50 ,ul of 0.1% sodium
dodecyl sulfate, reprecipitated with sec-butanol, then
washed with 200 ,ul of 100% ethanol. Samples were resus-
pended in formamide loading buffer, heated to 95°C for 5
min, and then loaded on a 12% polyacrylamide-8 M urea
wedge gel.
RESULTS
Proper spacing between the X and Y boxes is required for
HLA-DRA promoter function. We have previously shown
that the X and Y elements are required for proper DRA
function, since mutation of either the X element or the Y
element results in a reduction in promoter function to 67 or
51% of control, respectively (55). To evaluate the role of the
conserved 19-bp spacer which separates the X and Y ele-
ments in DRA promoter function, we constructed a series of
spacing mutants which alter the distance between the X and
Y boxes by integral and half-integral turns of the DNA helix
(Fig. 1). The insertion constructs contain nucleotide inser-
tions of 20 bp (pSpacer+20), 15 bp (pSpacer+15), 10 bp
(pSpacer+10), or 5 bp (pSpacer+5), representing 2.0, 1.5,
1.0, or 0.5 additional turn of the DNA helix, respectively. All
insertions were made at position -85 bp of an otherwise
unaltered -110-bp DRA promoter fragment. Similarly, the
deletion constructs have 10 bp (pSpacer-10) or 5 bp
(pSpacer-5) removed from the spacer region, representing a
loss of 1.0 or 0.5 turn of the DNA helix. Alterations of the
spacer between X and Y by 0.5 or 1.5 turns of the helix
would align the X and Y elements on the opposite side of the
DNA helix, thereby abolishing any interactions which re-
quire the X- and Y-box-binding proteins to bind on the same
side of the double helix. Likewise, alterations of the spacer
by one or two complete helical turns would change the
distance between the X and Y boxes, but the two elements
would remain on the same side of the DNA helix.
To assess DRA promoter activity, the various spacer
mutants and the wild-type control (5'A-56X+Y) were tran-
siently transfected into Raji cells, a B lymphoblastoid cell
line that constitutively expresses high levels of HLA-DRA
transcripts. The mean CAT activities of five independent
transfections are shown in Fig. 2. As previously reported,
substantial DRA promoter activity was observed with the
construct 5'A-56X+Y, which contains the wild-type class II
box (56). This control yields an average acetylation of 20%.
When integral turns of the DNA helix were inserted into the
X,Y spacer region, DRA promoter activity was increased
above the value for the wild-type control. Transfection with
pSpacer+20 resulted in CAT activity 1.68 + 0.27-fold that of
the wild-type control, while pSpacer+10 activity was 1.37 ±
0.30-fold that of the wild-type control (Fig. 2). In contrast,
insertion or deletion of half-integral turns of the DNA helix,
represented by pSpacer+15, pSpacer+5, and pSpacer-5,
showed markedly diminished promoter activity. Unexpect-
edly, deletion of 10 bp from the spacer also diminished
promoter activity to 53% of the control value. The
pSpacer-10 construct maintains the X and Y elements on
the same side of the DNA helix but brings the two elements
to within 9 bp of one another. Loss of promoter activity with
this construct may have occurred because the X- and Y-box
protein binding sites have been brought too close together
for proper assembly of a functional promoter-proximal tran-
scription complex. Another possibility is that a recently
defined human X-box-binding protein (hXBP-1) contact res-
idue has been deleted, possibly destabilizing or interfering
with X-box binding (33). Nonetheless, the ability of
pSpacer+20 and pSpacer+10, and the inability of
pSpacer+15, pSpacer+5, and pSpacer-5, to be efficiently
transcribed is coincidental with the number of helical repeats
between the X and Y elements.
To determine whether the transient transfection results
are observed at the RNA level, S1 nuclease protection
analyses were performed to map the transcriptional start site
and to quantitate the levels of correctly initiated transcripts
(Fig. 3). The riboprobe used in the Si nuclease analyses
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FIG. 2. Effect of helical alterations on DRA promoter function. The data are presented as relative CAT activity versus spacing alterations.
Relative CAT activity was determined by normalizing the percent acetylation of the chloramphenicol substrate to that of the 5'A-56X+Y
wild-type control, which was arbitrarily assigned a value of 1.00. The 5'A-56X+Y wild-type control is represented on the x axis as 0 spacing,
and all other spacing constructs are represented as the number of nucleotides inserted or deleted from the spacer region. Each point on the
graph represents the mean of five independent experiments. X, Mean of the normalized values; SE, standard error of the mean. The data
points in the graph correspond to the X value shown for each construct in the table at the right.
consists of 266 bp of DRA promoter sequence, the cap site,
27 bp of DRA sequence 3' to the cap site, and 266 bp of the
CAT structural gene (3). Correctly initiated transcripts from
the DRA-CAT constructs protect a 293-bp fragment (Fig.
3B) from Si digestion. Quantitation of the correctly initiated
transcripts from the spacer mutants and the wild-type con-
trol (Fig. 3B, lanes 2 to 8) reveals a pattern similar to that
seen in the transient transfection assay (Fig. 3A, lanes 2 to
8). Again, pSpacer+20 and pSpacer+10 showed greater
levels of DRA-specific transcripts in comparison with
pSpacer+ 15, pSpacer+5, and pSpacer-5, while
pSpacer-10 showed intermediate levels of transcripts in
comparison with the wild-type control. These data confirm
that the cyclic changes observed at the protein level directly
reflect accurate transcriptional activity from the mutant
DRA promoters. Other control lanes include 5'A-56, which
lacks the class II box, and tRNA, which does not hybridize
to the antisense probe (Fig. 3B, lanes 1 and 9, respectively).
Nuclear proteins bind the class II box regardless of spacing
alterations. Transcription from the DRA promoter requires
multiple protein factors which bind the X and Y elements (6,
9, 15, 17, 34, 42, 50). To determine whether the loss of
promoter function upon misalignment of the X and Y boxes
is due to the loss of protein binding to these elements, we
first performed competition assays. A 50-bp oligonucleotide
encompassing the wild-type DRA class II box was radiola-
beled and allowed to react with nuclear proteins prepared
from Namalwa B cells (identical results were obtained with
Raji and HeLa nuclear extracts). Four specific protein-DNA
complexes labeled Bi, B2/B3, and B4 were formed (Fig. 4A,
lane 1; Fig. 4B, lane 1). The complex labeled B2/B3 appears
as a single band in this particular experiment but has been
reproducibly shown to resolve as a doublet (data not shown).
To show specificity of the protein-DNA complexes, compe-
tition with a 50-fold molar excess of homologous unlabeled
Cv
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FIG. 3. Promoter function of spacing constructs analyzed by S1
nuclease protection analysis. (A) CAT assay; (B) S1 nuclease
protection experiment. The plasmids used to transfect Raji cells
before RNA isolation are listed above the lanes. RNA was isolated
24 h after transfection, and S1 analysis was performed. Lanes 1 to 8
of the CAT assay correspond to lanes 1 to 8 of the Si analysis. The
same controls were used for both assays. Lane 9 of the S1 analysis
represents a tRNA control. The markers (lane 10) are end-labeled
fragments of HpaII-cut plasmid pBR322. The 309-bp marker frag-
ment and the authentic 293-bp transcript are marked. Assays of
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FIG. 4. Competition gel mobility shift assay using spacer oligonucleotides. In panel A, the left-most lane shows the DNA-protein
complexes (Bi to B4) formed by Namalwa nuclear extracts and the wild-type X, spacer, and Y (X+Y) probe. Competitor oligonucleotides
are listed above the other lanes. A 50 x competition represents a 50-fold molar excess of the unlabeled oligonucleotide shown above each lane.
Preparation and quantitation of these competitor oligonucleotides are described in detail in Materials and Methods. (B) Gel mobility shift
assay using unrelated EL-3 competitor. Lanes 1 and 2 correspond respectively to the uncompeted X+Y protein-DNA complexes and to a
sample in competition with a 200-fold excess of homologous unlabeled X+Y competitor. Lane 3 shows a 200-fold competition of the X+Y
probe with the unrelated EL-3 competitor. Panels A and B show separate experiments, although all samples in each panel were performed
on the same gel.
competitor DNA (X+Y) was performed. This resulted in a
significant reduction of the specific B1 and B4 complexes
and a complete loss of the weaker B3 complex (Fig. 4A, lane
2). Gel mobility shift competition assays using greater (100-,
200-, and 400-fold) molar excesses of competitive oligonu-
cleotides resulted in complete elimination of the B1 and B4
complexes (data not shown).
To more precisely define the involvement of the X and Y
elements in formation of complexes Bi to B4, various
oligonucleotides were used as competitors (data not shown).
B1 was partially inhibited by a 50-fold excess of a Y+spacer
oligonucleotide and mostly inhibited by a 200-fold excess of
the same competitor. In addition, Bi was also partially
inhibited by a 200-fold but not a 50-fold excess of a
X+spacer oligonucleotide. This result suggests that the Y
element is a predominant contributor to the formation of this
complex, while the X element may also play a role. This
conclusion agrees with the methylation interference analysis
shown below. Analysis of column-fractionated B2 shows
that it could be inhibited by Y+spacer but not X+spacer,
suggesting that it consists of a protein complex formed with
the Y element (63a). B3 could be inhibited by X+spacer but
not Y+spacer, suggesting that it involves complex formation
with the X element. B4 most likely represents complex
formation with the X element because a 50-fold excess of a
X+spacer oligonucleotide blocked the formation of this
complex, but a similar oligonucleotide with mutated X
element was ineffective.
To assess the capacity of the X and Y elements to bind
nuclear proteins when separated by distances other than the
conserved 19-bp spacer, the oligonucleotides containing
spacer alterations were used as competitors in the gel shift
assay. These spacer competitors were prepared by polymer-
ase chain reaction amplification from the oligonucleotides
shown in Fig. 1. These oligonucleotides have insertions and
deletions within the spacer region and correspond to the
oligonucleotides used to generate the pSpacer constructs.
The competitors were quantitated by spectrophotometric
readings and by ethidium staining of agarose and polyacryl-
amide gels because accurate quantitation is critical for
allowing direct comparison between the different competi-
tors. Competition gel shift analysis was performed by first
allowing the nuclear extract to react with unlabeled compet-
itor DNA. Subsequently, the radiolabeled probe (X+Y) was
added and the protein-DNA complexes were separated by
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be expected to compete for nuclear proteins unless proper
stereospecific alignment is required for protein binding.
Competition with a 50-fold molar excess of each of the
altered spacer oligonucleotides resulted in a significant re-
duction of all four protein-DNA complexes (Fig. 4A; com-
pare lanes 3 to 8 with lane 1), whereas competition with an
unrelated competitor did not diminish any of the specific
complexes (Fig. 4B; compare lane 3 with lane 1). This finding
indicates that stable binding of the X- and Y-box-binding
proteins can occur regardless of the relative helical orienta-
tion between the X and Y elements and that protein binding
to the class II box is not sufficient for DRA promoter
function.
Notably, all of the oligonucleotides containing spacing
alterations could compete for X- and Y-box-binding pro-
teins, but careful serial dilution of the spacer competitors
revealed subtle differences in their quantitative ability to
compete for the Bl DNA-protein complex (Fig. 4A; compare
lanes 3 to 8 with lane 2). These subtle differences were
consistently seen with three batches of cold competitors that
had been independently prepared, suggesting that the differ-
ences are not due to small errors in competitor quantitation.
Curiously, densitometric scanning (data not shown) of Bi in
the gel mobility shift assay revealed that although all con-
structs could compete at least as well as the wild-type
control, pSpacer+20 and pSpacer+10 were better competi-
tors than the other constructs. This result parallels their
functional activity showing that pSpacer+20 and pSpacer+10
were functionally more active than the wild-type control
(Fig. 2). Whether these subtle differences in the ability to
bind protein have any functional importance requires further
examination.
Loss of promoter function is not due to altered protein-DNA
contact points. The gel shift analysis clearly shows that X and
Y proteins can bind the class II boxes regardless of helical
alterations. To determine whether changes in the alignment
of X and Y affect correct nucleotide contact points, and
hence promoter function, we performed methylation inter-
ference analysis. We mapped the guanosine residues which,
when methylated, interfere with protein binding. This anal-
ysis was done with the functional (spacer+10) and less
functional (spacer+5) oligonucleotides, and these contact
residues were compared with the contacts of the wild-type
X+Y oligonucleotide (Fig. 5). We have previously reported
that the Bi complex protects the Y element on both the
coding and noncoding strands, with inconsistent protection
over the X element on the noncoding strand (55). Here we
have found that methylation of the X+Y probe consistently
interferes with complex formation at both the X and Y
elements on the noncoding strand and at only the Y element
of the coding strand (Fig. 5A), implying that Bi is a complex
formed by proteins binding the X and Y elements. These
observations have been confirmed by densitometric analysis
(data not shown). Our ability to detect consistent interfer-
ence over the X region is a result of different batches of
poly(dI-dC) and altered gel shift conditions which optimize
protein binding. The methylation interference pattern of the
Bi complex formed by spacer+5 was found to have contact
residues identical to those of the wild-type X+Y probe (Fig.
5A and B). However, the interference patterns of the Bi
complex formed with the spacer+ 10 probe showed two
additional weak contact points (Fig. 5C). These contacts
were consistent for two independent experiments, suggest-
ing that separation of the X and Y elements by an additional
10 bp allows the X- and Y-box-binding proteins to contact
their cognate DNA elements at additional residues, possibly
forming a more stable protein-DNA complex. Since the
pSpacer+ 10 construct functions better than the 5'A-56X+Y
control, we suspect that this altered protein-DNA interac-
tion may facilitate better transcription. Attempts to identify
the contact points of the B2, B3, and B4 bands were
unsuccessful because of their relatively weak binding. These
data (Fig. 5D) indicate that the loss of promoter activity in
the pSpacer+5 construct is not due to the inability of the X-
and Y-box-binding proteins to correctly contact the X and Y
elements. In addition, the increased promoter activity of the
pSpacer+ 10 construct may be due to increased stability of
the X-Y complex, since additional protein-DNA contact
points have been identified with this construct.
DISCUSSION
Although the proximal cis-acting elements involved in the
activity of the MHC class II promoters have been defined,
the protein-protein interactions which are necessary to
achieve the complex regulation of class II expression are not
well understood. Our insertion and deletion constructs were
designed to address whether the conserved 19-bp spacing
between the X and Y elements was necessary to allow
protein-protein interactions within the proximal region of the
DRA promoter. Studies using these constructs clearly show
that proper DRA promoter function requires the X and Y
elements to be stereospecifically aligned. Insertion con-
structs, with distances separating the X and Y elements by
39 bp (pSpacer+20) and 29 bp (pSpacer+10), create protein
recognition sites which are aligned on the same side of the
DNA helix, as is the case for the wild-type 19-bp spacer. The
ability of these constructs to function at least as well as the
wild-type construct may be explained in that stereospecific
alignment between the two elements allows the X- and
Y-box-binding proteins to either interact directly or partici-
pate in the assembly of a larger promoter complex. In
contrast, constructs containing 34 bp (pSpacer+15), 24 bp
(pSpacer+5), or 14 bp (pSpacer-5) would position the X and
Y elements on opposite sides of the helix, thereby abolishing
their ability to interact directly or indirectly. Modeling of the
contact points identified by methylation interference analy-
sis clearly shows the stereospecific alignment of the X and Y
boxes when integral and half-integral turns separate these
elements (Fig. 6). The contact points identified by methyla-
tion interference are depicted by arrows and then plotted on
the double helix. In the wild-type X+Y construct, the
contact points fall on the same face of the double helix. The
same would be true of the pSpacer+10 construct. In con-
trast, plotting the contact points in pSpacer+5 reveals that
the X- and Y-box-binding proteins would be oriented on
opposite sides of the double helix. The same results would
be predicted with the pSpacer+15, pSpacer+5, and
pSpacer-5 constructs. This would explain the inability of
these constructs to promote transcription. The conservation
of the X and Y elements and the need for proper spacing
between these elements strongly suggest that the X- and
Y-box-binding proteins are involved either directly or indi-
rectly as components of a larger transcription complex.
However, we cannot exclude the possibility that the stereo-
specific alignment between the X box and further-down-
stream elements such as the octamer or the TATA element is
important.
It is noteworthy that the methylation interference pattern
of B1 coincides with that of hXBP-1 (33) on the X element
and the biochemically purified YEBP on the Y element (the
relationship between the human YEBP and the cloned
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FIG. 6. Modeling of the stereospecific alignment between the X and Y elements in the wild-type X+Y and the spacer+5 oligonucleotides.
The DNA sequences of the X and Y elements on both the coding and noncoding strands are shown to scale on a double helix. The black dots
within the DNA helix are accurately plotted and represent the contact residues of X- and Y-box-binding proteins as determined in the
methylation interference analysis (most likely hXBP-1 and YEBP proteins). These contact points are also indicated by the arrow marking the
DNA sequence. The shaded portion depicts the back side of the double helix, and the white portion represents the front of the helix. The
guanosine residue shown in parentheses on strand 1 is within the spacer sequence.
murine NF-Y clones has not been determined, although they
are most likely homologous). These data suggest that this
complex consists of both X- and Y-element-binding proteins.
Interestingly, according to the model depicted in Fig. 6, the
contact points of hXBP-1 and YEBP are actually stereospe-
cifically aligned on the same phase of the DNA. In contrast,
binding of another X-element-specific protein (RF-X) would
result in this X-element-binding protein being on the oppo-
site side of the DNA double helix relative to the Y-element-
binding protein. We speculate that hXBP-1 and YEBP are
aligned so that interactions between them could occur;
however, direct experimentation is required to reach this
conclusion.
The model that the X and Y elements must be stereospe-
cifically aligned for DRA function is further supported by
analysis of the MHC class II-associated Ti-chain promoter.
Expression of MHC class II a- and 13-chain genes is coordi-
nately regulated with expression of the Ii-chain gene. The
mechanism of this coordinate regulation is not clear, but
recently X and Y homologs have been identified as func-
tional cis-acting elements of the Ii-chain promoter (8, 19, 21,
65). Paradoxically, the X and Y elements within the li-chain
promoter are separated by a 14-bp spacer. Careful analysis
of the critical CCAAT residues within the Y element reveals
that the li-chain and DRA CCAAT sequences are on oppo-
site strands. This would maintain the stereospecific align-
ment between the X and Y elements within the Ii-chain
promoter (8).
The constructs pSpacer+20, pSpacer+ 10, and pSpacer-10
were used to address whether there is a distance as well as
orientation requirement. It could be predicted that if stereo-
specific alignment were the only requirement for X and Y
function, then any number of integral turns separating the X
and Y elements would confer function to the promoter, yet
all murine and human class II genes have evolutionarily
conserved this distance at approximately two turns of the
DNA helix. We found that pSpacer+20 and pSpacer+10
function slightly better than the wild-type 5'A-56X+Y con-
struct and that pSpacer- 10 functions at 53% of control. The
ability of pSpacer+20 and pSpacer+10 to function suggests
that it is relative helical orientation rather than precise
spacing that is most important in DRA promoter function.
One possible explanation for the enhanced function of
pSpacer+20 and pSpacer+10 is that these constructs are
able to form a more stable protein-protein (or multiprotein)
complex than can the wild-type control. Evidence support-
ing this mechanism is revealed in the gel mobility shift
competition experiment (Fig. 4). Here we have found that
spacer+20 and spacer+10 compete more efficiently for the
X- and Y-box-binding proteins than does the wild-type
control. This mechanism is further supported by the meth-
ylation interference analysis showing that spacer+10 shows
weak interference at additional guanosine residues com-
pared with the wild-type X+Y and spacer+5 probes (Fig.
SC). The ability of the X- and Y-box-binding proteins to
contact additional residues may result in a more stable
protein-protein complex. Expansion of distance between
two promoter elements leading to increased promoter func-
tion has been previously seen in the thymidine kinase gene of
herpes simplex virus (39).
FIG. 5. Methylation interference analysis of the Bi complex. Panels A, B, and C correspond to X+Y wild-type oligonucleotide, spacer+5
oligonucleotide, and spacer+ 10 oligonucleotide, respectively. X and Y consensus sequences are shown, and guanosine residues are marked
by lines to the corresponding band in the gel. Nucleotides are numbered relative to the cap site. Numbering of the spacer mutants (spacer+5
and spacer+ 10) reflect 5- and 10-bp insertions. A longer arrow depicts residues where methylation strongly interferes with protein binding.
A shorter arrow depicts residues where binding is weakly interfered with. The guanosine residue in parentheses next to the X element of the
noncoding strand represents the most 5' residue of the spacer sequence and is not part of the X consensus sequence. On the noncoding strand
of panel C, this residue appears as a doublet. This is an artifact due to cracking of the gel upon drying. Lanes: B, bound DNA; F, free DNA.
(D) Summary of the data contained in panels A to C. Arrow size reflects strong versus weak interference.
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In light of the evidence presented here, it is apparent that
considerable changes in the distance between the X and Y
elements can be tolerated. Formation of a functional pro-
moter complex, either through direct or indirect X-Y inter-
action, requires that the proteins be flexible enough to
compensate for the additional distance between these ele-
ments. Alternatively, the intervening DNA must be flexible
enough to loop out and allow the X- and Y-box-binding
proteins to form a functional promoter complex. It seems
unlikely that the X- and Y-box-binding proteins could com-
pensate for an increased distance of two DNA helical turns,
although this possibility cannot be excluded. A more likely
explanation is that the spacer DNA is flexible enough to
allow the intervening DNA to form a loop structure. In the
19-bp wild-type spacer, the distance may be close enough
that looping is not required, but as the distance increases,
the proteins could continue to interact if their binding sites
are located on the same side of the double helix, by looping
of the intervening DNA. This difference may account for the
differences in the methylation interference patterns of spac-
er+10 and the wild-type control. In some systems in which
stereospecific alignment between cis-acting elements is re-
quired, considerable length alterations have also been noted,
suggesting direct interaction with looping of the intervening
spacer DNA (27, 58).
Taken together, our data clearly demonstrate that the
conserved 19-bp spacer found in the DRA promoter func-
tions to stereospecifically align the X and Y elements. This
requirement for stereospecific alignment suggests either that
direct protein-protein interactions occur between the X- and
Y-box-binding proteins or that the X- and Y-box-binding
proteins need to be stereospecifically aligned for proper
assembly of a larger promoter complex. Because all murine
and human MHC class II genes have evolutionarily con-
served the X and Y boxes and the two-helical-turn spacer,
we predict that an interaction involving the X- and Y-box-
binding proteins is a universal requirement in the regulation
of all MHC class II genes. Future studies will be directed at
identifying which of the X- and Y-box-binding proteins
participate in this interaction and assessing the role of the
other X- and Y-box-binding proteins in the transcriptional
regulation of the DRA promoter.
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